Thu, November 9, 2023

John Newman Maintained (ACET) at Strong Buy with Decreased Target to $21 on, Nov 9th, 2023

John Newman of Canaccord Genuity, Maintained "Adicet Bio, Inc." (ACET) at Strong Buy with Decreased Target from $28 to $21 on, Nov 9th, 2023.

John has made no other calls on ACET in the last 4 months.



There are 3 other peers that have a rating on ACET. Out of the 3 peers that are also analyzing ACET, 0 agree with John's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with John


  • Asthika Goonewardene of "Truist Securities" Reiterated at Strong Buy and Held Target at $27 on, Wednesday, September 6th, 2023
  • Edward White of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $26 on, Friday, August 11th, 2023
  • Justin Zelin of "BTIG" Maintained at Strong Buy with Decreased Target to $10 on, Thursday, August 10th, 2023